Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 27

    1.

    Progesterone inhibition of Wnt/beta-catenin signaling in normal endometrium and endometrial cancer.

    Wang Y, Hanifi-Moghaddam P, Hanekamp EE, Kloosterboer HJ, Franken P, Veldscholte J, van Doorn HC, Ewing PC, Kim JJ, Grootegoed JA, Burger CW, Fodde R, Blok LJ.

    Clin Cancer Res. 2009 Sep 15;15(18):5784-93. Epub 2009 Sep 8.PMID: 19737954 [PubMed - in process]Related articles

    2.

    Signaling by estrogens and tamoxifen in the human endometrium.

    Gielen SC, Santegoets LA, Hanifi-Moghaddam P, Burger CW, Blok LJ.

    J Steroid Biochem Mol Biol. 2008 Apr;109(3-5):219-23. Epub 2008 Mar 15.PMID: 18434135 [PubMed - indexed for MEDLINE]Related articles

    3.

    Deleterious CHEK2 1100delC and L303X mutants identified among 38 human breast cancer cell lines.

    Wasielewski M, Hanifi-Moghaddam P, Hollestelle A, Merajver SD, van den Ouweland A, Klijn JG, Ethier SP, Schutte M.

    Breast Cancer Res Treat. 2009 Jan;113(2):285-91. Epub 2008 Feb 24.PMID: 18297428 [PubMed - indexed for MEDLINE]Related articles

    4.

    The regulation and function of the forkhead transcription factor, Forkhead box O1, is dependent on the progesterone receptor in endometrial carcinoma.

    Ward EC, Hoekstra AV, Blok LJ, Hanifi-Moghaddam P, Lurain JR, Singh DK, Buttin BM, Schink JC, Kim JJ.

    Endocrinology. 2008 Apr;149(4):1942-50. Epub 2007 Dec 20.PMID: 18096667 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Difference in signalling between various hormone therapies in endometrium, myometrium and upper part of the vagina.

    Hanifi-Moghaddam P, Boers-Sijmons B, Klaassens AH, van Wijk FH, Van Ijcken WF, Van der Spek P, Verheul HA, Kloosterboer HJ, Burger CW, Blok LJ.

    Hum Reprod. 2008 Feb;23(2):298-305. Epub 2007 Dec 11.PMID: 18077316 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Genomic and nongenomic effects of estrogen signaling in human endometrial cells: involvement of the growth factor receptor signaling downstream AKT pathway.

    Gielen SC, Santegoets LA, Kühne LC, Van Ijcken WF, Boers-Sijmons B, Hanifi-Moghaddam P, Helmerhorst TJ, Blok LJ, Burger CW.

    Reprod Sci. 2007 Oct;14(7):646-54.PMID: 18000226 [PubMed - indexed for MEDLINE]Related articles

    8.

    HPV related VIN: highly proliferative and diminished responsiveness to extracellular signals.

    Santegoets LA, Seters M, Helmerhorst TJ, Heijmans-Antonissen C, Hanifi-Moghaddam P, Ewing PC, van Ijcken WF, van der Spek PJ, van der Meijden WI, Blok LJ.

    Int J Cancer. 2007 Aug 15;121(4):759-66.PMID: 17471573 [PubMed - indexed for MEDLINE]Related articles

    9.

    Association of immune mediators at diagnosis of Type 1 diabetes with later clinical remission.

    Schloot NC, Hanifi-Moghaddam P, Aabenhus-Andersen N, Alizadeh BZ, Saha MT, Knip M, Devendra D, Wilkin T, Bonifacio E, Roep BO, Kolb H, Mandrup-Poulsen T.

    Diabet Med. 2007 May;24(5):512-20. Epub 2007 Mar 22.PMID: 17381505 [PubMed - indexed for MEDLINE]Related articles

    10.

    Molecular analysis of human endometrium: short-term tibolone signaling differs significantly from estrogen and estrogen + progestagen signaling.

    Hanifi-Moghaddam P, Boers-Sijmons B, Klaassens AH, van Wijk FH, den Bakker MA, Ott MC, Shipley GL, Verheul HA, Kloosterboer HJ, Burger CW, Blok LJ.

    J Mol Med. 2007 May;85(5):471-80. Epub 2007 Jan 17.PMID: 17226044 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    The hormone replacement therapy drug tibolone acts very similar to medroxyprogesterone acetate in an estrogen-and progesterone-responsive endometrial cancer cell line.

    Hanifi-Moghaddam P, Sijmons B, Ott MC, van Ijcken WF, Nowzari D, Kuhne EC, van der Spek P, Kloosterboer HJ, Burger CW, Blok LJ.

    J Mol Endocrinol. 2006 Dec;37(3):405-13.PMID: 17170081 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Association of interferon-gamma and interleukin 10 genotypes and serum levels with partial clinical remission in type 1 diabetes.

    Alizadeh BZ, Hanifi-Moghaddam P, Eerligh P, van der Slik AR, Kolb H, Kharagjitsingh AV, Pereira Arias AM, Ronkainen M, Knip M, Bonfanti R, Bonifacio E, Devendra D, Wilkin T, Giphart MJ, Koeleman BP, Nolsøe R, Mandrup Poulsen T, Schloot NC, Roep BO; DIABMARKER Study Group.

    Clin Exp Immunol. 2006 Sep;145(3):480-4.PMID: 16907917 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Genetic variants of RANTES are associated with serum RANTES level and protection for type 1 diabetes.

    Zhernakova A, Alizadeh BZ, Eerligh P, Hanifi-Moghaddam P, Schloot NC, Diosdado B, Wijmenga C, Roep BO, Koeleman BP.

    Genes Immun. 2006 Oct;7(7):544-9. Epub 2006 Jul 20.PMID: 16855620 [PubMed - indexed for MEDLINE]Related articles

    14.

    Histological and immunohistochemical evaluation of postmenopausal endometrium after 3 weeks of treatment with tibolone, estrogen only, or estrogen plus progestagen.

    Klaassens AH, van Wijk FH, Hanifi-Moghaddam P, Sijmons B, Ewing PC, Ten Kate-Booij MJ, Kooi GS, Kloosterboer HJ, Blok LJ, Burger CW.

    Fertil Steril. 2006 Aug;86(2):352-61. Epub 2006 Jul 7.PMID: 16828477 [PubMed - indexed for MEDLINE]Related articles

    15.

    Growth regulation and transcriptional activities of estrogen and progesterone in human endometrial cancer cells.

    Gielen SC, Hanekamp EE, Hanifi-Moghaddam P, Sijbers AM, van Gool AJ, Burger CW, Blok LJ, Huikeshoven FJ.

    Int J Gynecol Cancer. 2006 Jan-Feb;16(1):110-20.PMID: 16445620 [PubMed - indexed for MEDLINE]Related articles

    16.

    Altered chemokine levels in individuals at risk of Type 1 diabetes mellitus.

    Hanifi-Moghaddam P, Kappler S, Seissler J, Müller-Scholze S, Martin S, Roep BO, Strassburger K, Kolb H, Schloot NC.

    Diabet Med. 2006 Feb;23(2):156-63.PMID: 16433713 [PubMed - indexed for MEDLINE]Related articles

    17.

    Analysis of estrogen agonism and antagonism of tamoxifen, raloxifene, and ICI182780 in endometrial cancer cells: a putative role for the epidermal growth factor receptor ligand amphiregulin.

    Gielen SC, Burger CW, Kühne LC, Hanifi-Moghaddam P, Blok LJ.

    J Soc Gynecol Investig. 2005 Oct;12(7):e55-67.PMID: 16202921 [PubMed - indexed for MEDLINE]Related articles

    18.

    Association of humoral immunity to human Hsp60 with the IL-6 gene polymorphism C-174G in patients with type 2 diabetes and controls.

    Mostafazadeh A, Herder C, Haastert B, Hanifi-Moghaddam P, Schloot N, Koenig W, Illig T, Thorand B, Holle R, Eslami MB, Kolb H; KORA Group.

    Horm Metab Res. 2005 Apr;37(4):257-63.PMID: 15952088 [PubMed - indexed for MEDLINE]Related articles

    19.

    Molecular portrait of the progestagenic and estrogenic actions of tibolone: behavior of cellular networks in response to tibolone.

    Hanifi-Moghaddam P, Gielen SC, Kloosterboer HJ, De Gooyer ME, Sijbers AM, van Gool AJ, Smid M, Moorhouse M, van Wijk FH, Burger CW, Blok LJ.

    J Clin Endocrinol Metab. 2005 Feb;90(2):973-83. Epub 2004 Nov 30.PMID: 15572424 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    An association of autoantibody status and serum cytokine levels in type 1 diabetes.

    Hanifi-Moghaddam P, Schloot NC, Kappler S, Seissler J, Kolb H.

    Diabetes. 2003 May;52(5):1137-42.PMID: 12716743 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Impaired glucose tolerance is associated with increased serum concentrations of interleukin 6 and co-regulated acute-phase proteins but not TNF-alpha or its receptors.

    Müller S, Martin S, Koenig W, Hanifi-Moghaddam P, Rathmann W, Haastert B, Giani G, Illig T, Thorand B, Kolb H.

    Diabetologia. 2002 Jun;45(6):805-12. Epub 2002 May 8.PMID: 12107724 [PubMed - indexed for MEDLINE]Related articles

    22.

    Serum IFN-gamma and IL-10 levels are associated with disease progression in non-obese diabetic mice.

    Schloot NC, Hanifi-Moghaddam P, Goebel C, Shatavi SV, Flohé S, Kolb H, Rothe H.

    Diabetes Metab Res Rev. 2002 Jan-Feb;18(1):64-70.PMID: 11921420 [PubMed - indexed for MEDLINE]Related articles

    23.

    Cholera toxin B pretreatment of macrophages and monocytes diminishes their proinflammatory responsiveness to lipopolysaccharide.

    Burkart V, Kim YE, Hartmann B, Ghiea I, Syldath U, Kauer M, Fingberg W, Hanifi-Moghaddam P, Müller S, Kolb H.

    J Immunol. 2002 Feb 15;168(4):1730-7.PMID: 11823504 [PubMed - indexed for MEDLINE]Related articlesFree article

    24.

    Cytokine secretion patterns in twins discordant for Type I diabetes.

    Kallmann BA, Lampeter EF, Hanifi-Moghaddam P, Hawa M, Leslie RD, Kolb H.

    Diabetologia. 1999 Sep;42(9):1080-5.PMID: 10447519 [PubMed - indexed for MEDLINE]Related articles

    25.

    Propofol prevents peroxide-induced inhibition of glutamate transport in cultured astrocytes.

    Sitar SM, Hanifi-Moghaddam P, Gelb A, Cechetto DF, Siushansian R, Wilson JX.

    Anesthesiology. 1999 May;90(5):1446-53.PMID: 10319794 [PubMed - indexed for MEDLINE]Related articlesFree article

    26.

    D6STNFa microsatellite locus correlates with CTLp frequency in unrelated bone marrow donor-recipient pairs.

    Hanifi Moghaddam P, Zwinderman A, Kazemi M, van der Voort Maarschalk M, Ruigrok M, Naipal A, van der Slik A, Oudshoorn M, Giphart MJ.

    Hum Immunol. 1998 May;59(5):295-301.PMID: 9619768 [PubMed - indexed for MEDLINE]Related articles

    27.

    Genetic structure of IDDM1: two separate regions in the major histocompatibility complex contribute to susceptibility or protection. Belgian Diabetes Registry.

    Hanifi Moghaddam P, de Knijf P, Roep BO, Van der Auwera B, Naipal A, Gorus F, Schuit F, Giphart MJ.

    Diabetes. 1998 Feb;47(2):263-9.PMID: 9519723 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...